| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.59e-05 | 3 | 48 | 2 | GO:0071691 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.94e-04 | 49 | 48 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 2.89e-04 | 56 | 48 | 3 | GO:0099091 | |
| HumanPheno | Bruising susceptibility | 8.63e-06 | 178 | 23 | 7 | HP:0000978 | |
| HumanPheno | Impaired collagen-induced platelet aggregation | 4.33e-05 | 16 | 23 | 3 | HP:0008320 | |
| HumanPheno | Impaired thrombin-induced platelet aggregation | 5.84e-05 | 3 | 23 | 2 | HP:0011872 | |
| HumanPheno | Prolonged bleeding time | 6.34e-05 | 50 | 23 | 4 | HP:0003010 | |
| HumanPheno | Subcutaneous hemorrhage | 9.60e-05 | 258 | 23 | 7 | HP:0001933 | |
| HumanPheno | Epistaxis | 9.69e-05 | 108 | 23 | 5 | HP:0000421 | |
| HumanPheno | Ecchymosis | 1.14e-04 | 58 | 23 | 4 | HP:0031364 | |
| HumanPheno | Menometrorrhagia | 1.93e-04 | 5 | 23 | 2 | HP:0400008 | |
| HumanPheno | Abnormal alpha granules | 1.93e-04 | 5 | 23 | 2 | HP:0012483 | |
| MousePheno | decreased erythroid progenitor cell number | 1.77e-05 | 58 | 38 | 4 | MP:0008973 | |
| MousePheno | decreased cardiac muscle relaxation | 7.16e-05 | 5 | 38 | 2 | MP:0020419 | |
| MousePheno | abnormal cardiac muscle relaxation | 7.90e-05 | 31 | 38 | 3 | MP:0004084 | |
| MousePheno | decreased immature B cell number | 1.14e-04 | 93 | 38 | 4 | MP:0008215 | |
| MousePheno | abnormal erythroid progenitor cell morphology | 1.51e-04 | 100 | 38 | 4 | MP:0008801 | |
| Domain | NEBU | 3.71e-05 | 4 | 47 | 2 | SM00227 | |
| Domain | Nebulin | 3.71e-05 | 4 | 47 | 2 | PF00880 | |
| Domain | Nebulin | 3.71e-05 | 4 | 47 | 2 | IPR013998 | |
| Domain | NEBULIN | 3.71e-05 | 4 | 47 | 2 | PS51216 | |
| Domain | Nebulin_repeat | 3.71e-05 | 4 | 47 | 2 | IPR000900 | |
| Domain | ARM-like | 5.68e-04 | 270 | 47 | 5 | IPR011989 | |
| Domain | CARBOXYPEPT_ZN_1 | 1.14e-03 | 20 | 47 | 2 | PS00132 | |
| Domain | Peptidase_M14 | 1.52e-03 | 23 | 47 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 1.52e-03 | 23 | 47 | 2 | IPR000834 | |
| Domain | ARM-type_fold | 1.57e-03 | 339 | 47 | 5 | IPR016024 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.10e-04 | 39 | 34 | 3 | MM15272 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 1.19e-04 | 40 | 34 | 3 | M27557 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.70e-04 | 45 | 34 | 3 | M27623 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 3.43e-04 | 57 | 34 | 3 | M19888 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION | 4.61e-04 | 63 | 34 | 3 | M39366 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 5.06e-04 | 65 | 34 | 3 | M38994 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 5.77e-04 | 68 | 34 | 3 | M48322 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.81e-04 | 15 | 34 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.81e-04 | 15 | 34 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.81e-04 | 15 | 34 | 2 | MM14959 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.81e-04 | 15 | 34 | 2 | MM14961 | |
| Pubmed | The mTOR-RUNX1 pathway regulates DC-SIGN expression in renal tubular epithelial cells. | 1.87e-06 | 2 | 48 | 2 | 31540687 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20538554 | ||
| Pubmed | Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis. | 1.87e-06 | 2 | 48 | 2 | 27869314 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 37801076 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 33247227 | ||
| Pubmed | Tissue and zonal-specific expression of an olfactory receptor transgene. | 1.87e-06 | 2 | 48 | 2 | 9412503 | |
| Pubmed | 2.80e-06 | 288 | 48 | 6 | 23383273 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 15292274 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 14525764 | ||
| Pubmed | ERK activation causes epilepsy by stimulating NMDA receptor activity. | 1.12e-05 | 4 | 48 | 2 | 17972914 | |
| Pubmed | Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway. | 1.12e-05 | 4 | 48 | 2 | 23022044 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 18952841 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 21241403 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 26621838 | ||
| Pubmed | The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolution. | 1.12e-05 | 4 | 48 | 2 | 32817592 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 23684925 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 22094587 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 18685811 | ||
| Pubmed | Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. | 1.86e-05 | 5 | 48 | 2 | 16824188 | |
| Pubmed | Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. | 1.86e-05 | 5 | 48 | 2 | 10605720 | |
| Pubmed | MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. | 1.86e-05 | 5 | 48 | 2 | 11965546 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 16353042 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 21034162 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 14963283 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 24011934 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 12518110 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 18803625 | ||
| Pubmed | Connection between genetically determined blood coagulation factors and haemorheology. | 2.79e-05 | 6 | 48 | 2 | 18503143 | |
| Pubmed | MOZ is essential for maintenance of hematopoietic stem cells. | 2.79e-05 | 6 | 48 | 2 | 16702405 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 17230042 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 20197096 | ||
| Pubmed | Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. | 2.79e-05 | 6 | 48 | 2 | 16157382 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 18836720 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 16567932 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 16635210 | ||
| Pubmed | Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. | 3.90e-05 | 7 | 48 | 2 | 11742995 | |
| Pubmed | Early pregnancy loss in celiac women: The role of genetic markers of thrombophilia. | 3.90e-05 | 7 | 48 | 2 | 19395327 | |
| Pubmed | Physical and functional link of the leukemia-associated factors AML1 and PML. | 3.90e-05 | 7 | 48 | 2 | 15331439 | |
| Pubmed | Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population. | 3.90e-05 | 7 | 48 | 2 | 15968394 | |
| Pubmed | Thrombophilic gene polymorphisms are risk factors for unexplained infertility. | 3.90e-05 | 7 | 48 | 2 | 18930220 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 27221710 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 25792870 | ||
| Pubmed | Impact of genetic polymorphisms on platelet function and aspirin resistance. | 6.67e-05 | 9 | 48 | 2 | 19923980 | |
| Pubmed | Candidate genetic markers and the risk of restenosis after coronary angioplasty. | 6.67e-05 | 9 | 48 | 2 | 12899665 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 38198889 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 16554481 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 19906129 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 19072566 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 19889638 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 12082590 | ||
| Pubmed | Vascular at-risk genotypes and disease severity in Lebanese sickle cell disease patients. | 8.33e-05 | 10 | 48 | 2 | 20425806 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 17111197 | ||
| Pubmed | Characterization of single-nucleotide polymorphisms in coding regions of human genes. | 1.11e-04 | 67 | 48 | 3 | 10391209 | |
| Pubmed | Genetic influences on lipid metabolism trait variability within the Stanislas Cohort. | 1.22e-04 | 12 | 48 | 2 | 11714857 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 12514663 | ||
| Pubmed | Genetic influences on blood pressure within the Stanislas Cohort. | 1.44e-04 | 13 | 48 | 2 | 15076187 | |
| Pubmed | Genetic cardiovascular risk factors and age-related macular degeneration. | 1.44e-04 | 13 | 48 | 2 | 19860767 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 16581250 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 16005629 | ||
| Pubmed | Gene polymorphisms in association with emerging cardiovascular risk markers in adult women. | 1.68e-04 | 14 | 48 | 2 | 20078877 | |
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 14746139 | ||
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 30466882 | ||
| Pubmed | Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis. | 2.21e-04 | 16 | 48 | 2 | 17521568 | |
| Pubmed | 2.37e-04 | 638 | 48 | 6 | 33239621 | ||
| Pubmed | Lp(a) and risk of recurrent cardiac events in obese postinfarction patients. | 2.50e-04 | 17 | 48 | 2 | 18927546 | |
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 2.81e-04 | 18 | 48 | 2 | 28864826 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 20887958 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 2.92e-04 | 942 | 48 | 7 | 31073040 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.12e-04 | 430 | 48 | 5 | 35044719 | |
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 3.85e-04 | 21 | 48 | 2 | 22959728 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 4.01e-04 | 704 | 48 | 6 | 29955894 | |
| Pubmed | 4.16e-04 | 709 | 48 | 6 | 22988430 | ||
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 12871600 | ||
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 24733831 | ||
| Pubmed | Regulation of Hematopoiesis and Methionine Homeostasis by mTORC1 Inhibitor NPRL2. | 4.23e-04 | 22 | 48 | 2 | 26166573 | |
| Pubmed | 5.05e-04 | 24 | 48 | 2 | 32043969 | ||
| Pubmed | mTORC1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux. | 5.48e-04 | 25 | 48 | 2 | 30340022 | |
| Pubmed | 5.93e-04 | 26 | 48 | 2 | 21054877 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 6.30e-04 | 283 | 48 | 4 | 28533407 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.60e-04 | 774 | 48 | 6 | 15302935 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 7.57e-04 | 1105 | 48 | 7 | 35748872 | |
| Pubmed | 7.63e-04 | 129 | 48 | 3 | 23022380 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 7.81e-04 | 1455 | 48 | 8 | 22863883 | |
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 21300867 | ||
| Pubmed | 9.39e-04 | 1497 | 48 | 8 | 31527615 | ||
| Pubmed | 9.58e-04 | 33 | 48 | 2 | 30917309 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 1.01e-03 | 558 | 48 | 5 | 35063084 | |
| Pubmed | The genomic basis of cerebral palsy: a HuGE systematic literature review. | 1.02e-03 | 34 | 48 | 2 | 19238444 | |
| Pubmed | 1.08e-03 | 35 | 48 | 2 | 18513389 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.10e-03 | 569 | 48 | 5 | 30639242 | |
| Pubmed | 1.13e-03 | 331 | 48 | 4 | 20634891 | ||
| Pubmed | 1.20e-03 | 151 | 48 | 3 | 17043677 | ||
| Pubmed | 1.23e-03 | 152 | 48 | 3 | 19578796 | ||
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 1.27e-03 | 38 | 48 | 2 | 16263699 | |
| Cytoband | 1p22.2 | 3.98e-04 | 28 | 48 | 2 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.44e-03 | 797 | 48 | 5 | chr19p13 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 1.65e-05 | 85 | 47 | 4 | M41085 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 2.91e-05 | 200 | 47 | 5 | M4819 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 160 | 48 | 4 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 167 | 48 | 4 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 190 | 48 | 4 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 190 | 48 | 4 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 190 | 48 | 4 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 190 | 48 | 4 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.18e-05 | 190 | 48 | 4 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-05 | 192 | 48 | 4 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-05 | 192 | 48 | 4 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-05 | 192 | 48 | 4 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 193 | 48 | 4 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 193 | 48 | 4 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.51e-05 | 193 | 48 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | be55cef682ba87250dad97689332c8820b3a7420 | |
| Disease | Adenoid Cystic Carcinoma | 1.82e-05 | 100 | 46 | 4 | C0010606 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.88e-04 | 82 | 46 | 3 | EFO_0005658 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.09e-04 | 84 | 46 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | myocardial infarction (is_implicated_in) | 5.01e-04 | 99 | 46 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | Barrett's esophagus | 8.76e-04 | 28 | 46 | 2 | EFO_0000280 | |
| Disease | Thrombocytopenia | 9.40e-04 | 29 | 46 | 2 | C0040034 | |
| Disease | Epileptic encephalopathy | 1.01e-03 | 30 | 46 | 2 | C0543888 | |
| Disease | hypertension (implicated_via_orthology) | 1.06e-03 | 128 | 46 | 3 | DOID:10763 (implicated_via_orthology) | |
| Disease | androsterone sulfate measurement | 1.22e-03 | 33 | 46 | 2 | EFO_0021117 | |
| Disease | Bladder Neoplasm | 1.37e-03 | 140 | 46 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.39e-03 | 141 | 46 | 3 | C0005684 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AMRYGVESIYQAMTH | 866 | Q9UPW8 | |
| VMYTNGYEEMTFHGN | 486 | Q8IUX7 | |
| AYVMRYFESSGMTEH | 576 | P33076 | |
| ADPSFYTYMMTHAAA | 256 | Q03828 | |
| ETEDQGMYKYMSSQH | 1596 | Q9Y6D5 | |
| SMYSATKYMNGHSDV | 206 | P32929 | |
| EMGVSRSYTMESSYC | 976 | Q96MI9 | |
| DSMANSFVGTRSYMA | 221 | P36507 | |
| PSAHGMMDDYTYVSV | 121 | Q8N8D7 | |
| SYMHCNERMYRSGDA | 1471 | Q86VF7 | |
| TMTIHNGMFFSTYDR | 396 | P02675 | |
| YVSADMHRMAAAFNT | 381 | Q13098 | |
| HMMSLYSTHTYSRDC | 2146 | O94915 | |
| TSGGQMYHYDMNTAS | 326 | P04150 | |
| GLHSMYSDALMATTY | 266 | O60404 | |
| GLHSMYSDALMATTY | 266 | Q8NGA5 | |
| MMYTGPSHHSYMNAA | 1976 | Q92794 | |
| DHMGMTASYTSNLAY | 451 | Q14674 | |
| DAMFSTNYSHMENYR | 76 | Q96ID5 | |
| FSSHYGSENSMSYTM | 61 | Q9UKA2 | |
| AAAAAAMYSSMYRTP | 331 | Q9NY43 | |
| YYRTNHTVMTMGSDF | 306 | O00754 | |
| VGSDNHYSASTTMDY | 301 | P05106 | |
| TLTDDHSLYGGYMMS | 906 | A0A0U1RQI7 | |
| TAMAGESYSRAYGAM | 1576 | P42345 | |
| MSAMGSATRYHTYLP | 341 | Q01196 | |
| AHQMSLEGFTRYMDS | 126 | Q86YW0 | |
| TMSQFEMDTYAKSHD | 1721 | Q6ZNJ1 | |
| MQFSSLEHEGEYYMT | 91 | Q8IYU8 | |
| GMRTYYFSADTQEDM | 256 | Q6IQ23 | |
| VFYNSEYSMPSTHAM | 196 | Q9BX95 | |
| RSAYDSTMETMNYAQ | 576 | P53396 | |
| NMYYSQSSMFPHRSE | 41 | Q9NZN8 | |
| STHSQEMDSGTEYGM | 951 | Q9UKE5 | |
| TNGLYGYSWDMMVHS | 391 | P38435 | |
| YFRDHMSLNEMSTVS | 56 | Q5TC79 | |
| STNMMGHRVDYFIAS | 36 | Q99442 | |
| NAYSHTMSEYGRMTD | 76 | Q9P2W9 | |
| NMALSMYLSATGHYN | 181 | Q13336 | |
| LAVYGASYHSMSSMA | 61 | Q9BTX3 | |
| ASYHSMSSMARAAFS | 66 | Q9BTX3 | |
| QNYSSNAYHMSSTMK | 651 | Q9BZW7 | |
| AYARSSDMYSHMGTM | 66 | Q8N5H7 | |
| EHRMSGGSMYNSDTD | 186 | Q86XD8 | |
| YSAADRSMMSSYSAA | 1096 | P18583 | |
| SYSAADRSMMSSYTA | 1106 | P18583 | |
| YGSITSMGYESRDNM | 251 | Q9Y2L8 | |
| QRSMDSYLNQSYGMD | 46 | Q5BKZ1 | |
| YGYMHQTSVSSMRSM | 936 | O76041 | |
| YAHMFEMSAGESTFA | 1336 | Q13224 |